Orthocell Investor Centre
Orthocell is a publicly-traded company listed on the Australian Securities Exchange (ASX:OCC).
Advanced portfolio with significant clinical evidence and near-term commercial milestones.
GMP-certified and TGA-licensed manufacturing facility.
Comprehensive global patent portfolio.
Highly experienced board and management team.
OCC Share Price
"Our Company is pursuing a total addressable market for our dental, nerve and autologous tendon therapy products of US$17.7 billion per annum – a compelling investment and growth opportunity."
Orthocell MD, Paul Anderson
